Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1985 Sep;202(3):384–393. doi: 10.1097/00000658-198509000-00017

Predicting tumor response in patients with colorectal hepatic metastases.

J M Daly, J Butler, N Kemeny, S D Yeh, J A Ridge, J Botet, J R Bading, J J DeCosse, R S Benua
PMCID: PMC1250925  PMID: 2931055

Abstract

Until now, there has been no reliable means of predicting tumor response to chemotherapy in patients with metastatic colorectal cancer. Using arterial nuclide flow scans as a determinant of tumor response, the degree of tumor perfusion was evaluated in a blinded prospective study. Seventy-three patients with colorectal hepatic metastases received continuous hepatic arterial (N = 52) or systemic intravenous (N = 21) chemotherapy using an implantable pump. All patients had pretreatment hepatic arteriography and arterial flow scans using 99mTc macroaggregated albumin (99mTc-MAA). An arteriogram was characterized as positive if it showed tumor hypervascularity; the 99mTc-MAA flow scan was considered positive if it showed increased tumor uptake relative to the liver. Of 47 patients with an evaluable 99mTc-MAA flow scan who were treated with arterial infusion, 31 had a positive scan; in this group 16 responded to chemotherapy. The 99mTc-MAA scan was negative in 16 patients, of whom one responded to chemotherapy (p less than 0.006). The 99mTc-MAA scan had the greatest predictive value in previously untreated patients (sensitivity = 91%; specificity = 77%). The arteriogram was positive in 25 of 46 evaluable patients, but this finding had little predictive value for tumor response (sensitivity = 56%; specificity = 46%). Of 21 patients receiving systemic intravenous infusion, the scan was positive in nine patients, of whom seven responded to chemotherapy. The 99mTc-MAA scan was negative in 12 patients, of whom one responded to chemotherapy (sensitivity = 88%; specificity = 85%). When 99mTc-MAA-positive and -negative groups were compared, there were no differences in mean patient age, per cent liver involvement, tumor size, or plasma liver function tests. Hepatic tumor perfusion as determined by MAA arterial flow scan is a reliable predictor of tumor response in patients with metastases from large bowel cancer. The test provides a valuable criterion for selecting individuals for treatment of metastases from large bowel cancer by infusion chemotherapy.

Full text

PDF
386

Images in this article

385FIG. 1.
on p.385
385FIG. 2.
on p.385
386FIG. 3.
on p.386
386FIG. 4.
on p.386
390FIG. 7.
on p.390

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BREEDIS C., YOUNG G. The blood supply of neoplasms in the liver. Am J Pathol. 1954 Sep-Oct;30(5):969–977. [PMC free article] [PubMed] [Google Scholar]
  2. Balch C. M., Urist M. M., Soong S. J., McGregor M. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg. 1983 Nov;198(5):567–573. doi: 10.1097/00000658-198311000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bengmark S., Hafström L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer. 1969 Jan;23(1):198–202. doi: 10.1002/1097-0142(196901)23:1<198::aid-cncr2820230126>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  4. Bengtsson G., Carlsson G., Hafström L., Jönsson P. E. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg. 1981 May;141(5):586–589. doi: 10.1016/0002-9610(81)90057-x. [DOI] [PubMed] [Google Scholar]
  5. Blank R. J., Tysan I. B. Intra-arterial 131-I-macroaggregated albumin to define intrahepatic tumors: a possible method of quantitating tumor response to therapy. J Nucl Med. 1969 Jul;10(7):514–516. [PubMed] [Google Scholar]
  6. Bledin A. G., Kantarjian H. M., Kim E. E., Wallace S., Chuang V. P., Patt Y. Z., Haynie T. P. 99mTc-labeled macroaggregated albumin in intrahepatic arterial chemotherapy. AJR Am J Roentgenol. 1982 Oct;139(4):711–715. doi: 10.2214/ajr.139.4.711. [DOI] [PubMed] [Google Scholar]
  7. Bronstein B. R., Steele G. D., Jr, Ensminger W., Kaplan W. D., Lowenstein M. S., Wilson R. E., Forman J., Zamcheck N. The use and limitations of serial plasma carcinoembryonic antigen (CEA) levels as a monitor of changing metastatic liver tumor volume in patients receiving chemotherapy. Cancer. 1980 Jul 15;46(2):266–272. doi: 10.1002/1097-0142(19800715)46:2<266::aid-cncr2820460208>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  8. Buchwald H., Grage T. B., Vassilopoulos P. P., Rohde T. D., Varco R. L., Blackshear P. J. Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer. 1980 Mar 1;45(5):866–869. doi: 10.1002/1097-0142(19800301)45:5<866::aid-cncr2820450507>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  9. Cady B., Oberfield R. A. Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. Am J Surg. 1974 Feb;127(2):220–227. doi: 10.1016/0002-9610(74)90161-5. [DOI] [PubMed] [Google Scholar]
  10. Dakhil S., Ensminger W., Cho K., Niederhuber J., Doan K., Wheeler R. Improved regional selectivity of hepatic arterial BCNU with degradable microspheres. Cancer. 1982 Aug 15;50(4):631–635. doi: 10.1002/1097-0142(19820815)50:4<631::aid-cncr2820500403>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  11. Daly J. M., Kemeny N., Oderman P., Botet J. Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. Arch Surg. 1984 Aug;119(8):936–941. doi: 10.1001/archsurg.1984.01390200054013. [DOI] [PubMed] [Google Scholar]
  12. Gyves J. W., Ziessman H. A., Ensminger W. D., Thrall J. H., Niederhuber J. E., Keyes J. W., Jr, Walker S. Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT). J Nucl Med. 1984 Sep;25(9):972–977. [PubMed] [Google Scholar]
  13. Jaffe B. M., Donegan W. L., Watson F., Spratt J. S., Jr Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet. 1968 Jul;127(1):1–11. [PubMed] [Google Scholar]
  14. Kaplan W. D., D'Orsi C. J., Ensminger W. D., Smith E. H., Levin D. C. Intra-arterial radionuclide infusion: a new technique to assess chemotherapy perfusion patterns. Cancer Treat Rep. 1978 May;62(5):699–703. [PubMed] [Google Scholar]
  15. Kaplan W. D., Ensminger W. D., Come S. E., Smith E. H., D'Orsi C. J., Levin D. C., Takvorian R. W., Steele G. D., Jr Radionuclide angiography to predict patient response to hepatic artery chemotherapy. Cancer Treat Rep. 1980;64(12):1217–1222. [PubMed] [Google Scholar]
  16. Kemeny N., Braun D. W., Jr Prognostic factors in advanced colorectal carcinoma. Importance of lactic dehydrogenase level, performance status, and white blood cell count. Am J Med. 1983 May;74(5):786–794. doi: 10.1016/0002-9343(83)91066-5. [DOI] [PubMed] [Google Scholar]
  17. Kim D. K., Watson R. C., Pahnke L. D., Fortner J. G. Tumor vascularity as a prognostic factor for hepatic tumors. Ann Surg. 1977 Jan;185(1):31–34. doi: 10.1097/00000658-197701000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. King E. G., Wood D. E., Morley T. P., Colapinto R. Scanning with macroaggregates of radioiodinated human serum albumin as an adjunct to celiac arteriography: a preliminary communication. Can Med Assoc J. 1966 Dec 10;95(24):1225–1227. [PMC free article] [PubMed] [Google Scholar]
  19. Lahr C. J., Soong S. J., Cloud G., Smith J. W., Urist M. M., Balch C. M. A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol. 1983 Nov;1(11):720–726. doi: 10.1200/JCO.1983.1.11.720. [DOI] [PubMed] [Google Scholar]
  20. Niederhuber J. E., Ensminger W., Gyves J., Thrall J., Walker S., Cozzi E. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer. 1984 Mar 15;53(6):1336–1343. doi: 10.1002/1097-0142(19840315)53:6<1336::aid-cncr2820530620>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  21. SULLIVAN R. D., NORCROSS J. W., WATKINS E., Jr CHEMOTHERAPY OF METASTATIC LIVER CANCER BY PROLONGED HEPATIC-ARTERY INFUSION. N Engl J Med. 1964 Feb 13;270:321–327. doi: 10.1056/NEJM196402132700701. [DOI] [PubMed] [Google Scholar]
  22. Sasaki Y., Imaoka S., Hasegawa Y., Nakano S., Ishikawa O., Ohigashi H., Taniguchi K., Koyama H., Iwanaga T., Terasawa T. Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer. 1985 Jan 15;55(2):311–316. doi: 10.1002/1097-0142(19850115)55:2<311::aid-cncr2820550202>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  23. Silverberg E. Cancer statistics, 1985. CA Cancer J Clin. 1985 Jan-Feb;35(1):19–35. doi: 10.3322/canjclin.35.1.19. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES